Vir Biotechnology, Inc. Insider Trading for July 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Vir Biotechnology, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Vir Biotechnology, Inc. for July 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 30 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Option Exercise | M | 1.53 | 7,900 | 12,087 | 508,155 | |
Jul 30 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Sell | S | 47.99 | 7,900 | 379,090 | 0 | 7.9 K to 0 (-100.00 %) |
Jul 30 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Buy | M | 1.53 | 7,900 | 12,087 | 7,900 | 0 to 7.9 K |
Jul 30 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Option Exercise | M | 1.53 | 7,900 | 12,087 | 508,155 | |
Jul 30 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Sell | S | 47.99 | 7,900 | 379,090 | 0 | 7.9 K to 0 (-100.00 %) |
Jul 30 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Buy | M | 1.53 | 7,900 | 12,087 | 7,900 | 0 to 7.9 K |
Jul 16 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Option Exercise | M | 1.53 | 7,900 | 12,087 | 516,055 | |
Jul 16 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Sell | S | 48.85 | 7,900 | 385,876 | 0 | 7.9 K to 0 (-100.00 %) |
Jul 16 2020 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Buy | M | 1.53 | 7,900 | 12,087 | 7,900 | 0 to 7.9 K |
Jul 16 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Option Exercise | M | 5.18 | 2,314 | 11,975 | 74,024 | |
Jul 16 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Option Exercise | M | 1.58 | 10,186 | 16,043 | 98,147 | |
Jul 16 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Sell | S | 49.52 | 7,500 | 371,435 | 15,777 | 23.3 K to 15.8 K (-32.22 %) |
Jul 16 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Sell | S | 49.54 | 5,000 | 247,683 | 23,277 | 28.3 K to 23.3 K (-17.68 %) |
Jul 16 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Buy | M | 5.18 | 2,314 | 11,975 | 28,277 | 26 K to 28.3 K (+8.91 %) |
Jul 16 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Buy | M | 1.58 | 10,186 | 16,043 | 25,963 | 15.8 K to 26 K (+64.56 %) |
Jul 15 2020 | VIR | Vir Biotechnology, ... | Horn Howard | CFO | Sell | S | 50.06 | 30,000 | 1,501,731 | 177,777 | 207.8 K to 177.8 K (-14.44 %) |
Jul 14 2020 | VIR | Vir Biotechnology, ... | Sigal Charles Elliott | Director | Option Exercise | A | 48.71 | 57,777 | 2,814,318 | 57,777 | |
Jul 14 2020 | VIR | Vir Biotechnology, ... | Sigal Charles Elliott | Director | Option Exercise | A | 48.71 | 57,777 | 2,814,318 | 57,777 | |
Jul 02 2020 | VIR | Vir Biotechnology, ... | Parrish Jay | Chief Business Offi ... | Option Exercise | M | 1.58 | 49,075 | 77,293 | 62,035 | |
Jul 02 2020 | VIR | Vir Biotechnology, ... | Parrish Jay | Chief Business Offi ... | Option Exercise | M | 1.49 | 25,925 | 38,499 | 46,296 | |
Jul 02 2020 | VIR | Vir Biotechnology, ... | Parrish Jay | Chief Business Offi ... | Sell | S | 37.95 | 75,000 | 2,846,310 | 222,222 | 297.2 K to 222.2 K (-25.23 %) |
Jul 02 2020 | VIR | Vir Biotechnology, ... | Parrish Jay | Chief Business Offi ... | Buy | M | 1.58 | 49,075 | 77,293 | 297,222 | 248.1 K to 297.2 K (+19.78 %) |
Jul 02 2020 | VIR | Vir Biotechnology, ... | Parrish Jay | Chief Business Offi ... | Buy | M | 1.49 | 25,925 | 38,499 | 248,147 | 222.2 K to 248.1 K (+11.67 %) |
Jul 02 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Option Exercise | M | 5.18 | 9,722 | 50,311 | 76,338 | |
Jul 02 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Option Exercise | M | 1.58 | 2,778 | 4,375 | 108,333 | |
Jul 02 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Sell | S | 37.77 | 5,000 | 188,841 | 15,777 | 20.8 K to 15.8 K (-24.07 %) |
Jul 02 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Sell | S | 37.79 | 7,500 | 283,412 | 23,277 | 30.8 K to 23.3 K (-24.37 %) |
Jul 02 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Buy | M | 5.18 | 9,722 | 50,311 | 28,277 | 18.6 K to 28.3 K (+52.40 %) |
Jul 02 2020 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Buy | M | 1.58 | 2,778 | 4,375 | 18,555 | 15.8 K to 18.6 K (+17.61 %) |
Jul 02 2020 | VIR | Vir Biotechnology, ... | Horn Howard | CFO | Sell | S | 40.00 | 10,000 | 400,000 | 207,777 | 217.8 K to 207.8 K (-4.59 %) |
Jul 02 2020 | VIR | Vir Biotechnology, ... | Horn Howard | CFO | Sell | S | 39.33 | 400 | 15,732 | 217,777 | 218.2 K to 217.8 K (-0.18 %) |
Jul 02 2020 | VIR | Vir Biotechnology, ... | Horn Howard | CFO | Sell | S | 38.78 | 500 | 19,392 | 218,177 | 218.7 K to 218.2 K (-0.23 %) |
Jul 02 2020 | VIR | Vir Biotechnology, ... | Horn Howard | CFO | Sell | S | 37.72 | 9,100 | 343,275 | 218,677 | 227.8 K to 218.7 K (-4.00 %) |